Ausgabe 6/2013
Inhalt (8 Artikel)
Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer
Paola Ulivi, Rosella Silvestrini
PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic
Anne-Laure Papa, Almas Sidiqui, Sri Uma Aisvarya Balasubramanian, Sasmit Sarangi, Matthew Luchette, Shiladitya Sengupta, Rania Harfouche
Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole
Akhilesh Rawat, Gopisetty Gopal, Ganesharaja Selvaluxmy, Thangarajan Rajkumar
Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma
Bartosz Pula, Mateusz Olbromski, Andrzej Wojnar, Agnieszka Gomulkiewicz, Wojciech Witkiewicz, Maciej Ugorski, Piotr Dziegiel, Marzena Podhorska-Okolow
Increase in ezrin expression from benign to malignant breast tumours
Daphne Gschwantler-Kaulich, Camilla Natter, Stefan Steurer, Ingrid Walter, Almut Thomas, Mohamed Salama, Christian F. Singer
Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway
Jeong Su Park, Su Yun Choi, Jeong-Hyung Lee, Maria Lee, Eun Sook Nam, Ae Lee Jeong, Sunyi Lee, Sora Han, Myeong-Sok Lee, Jong-Seok Lim, Do Young Yoon, Yongil Kwon, Young Yang
Macrophages as potential targets for zoledronic acid outside the skeleton—evidence from in vitro and in vivo models
T. L. Rogers, N. Wind, R. Hughes, F. Nutter, H. K. Brown, I. Vasiliadou, P. D. Ottewell, I. Holen
siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells
Fatemeh Bagheri, Shahrokh Safarian, Mohamadreza Baghaban Eslaminejad, Nader Sheibani